Sphingosine kinase 2 and multiple myeloma

Nigel J. Pyne; Susan Pyne

doi:10.18632/oncotarget.17420

Sphingosine kinase 2 and multiple myeloma

Nigel J. Pyne
, Susan Pyne

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

33 Downloads (Pure)

Abstract

News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.

Original language	English
Article number	17420
Pages (from-to)	43596-43597
Number of pages	2
Journal	Oncotarget
Volume	8
Issue number	24
DOIs	https://doi.org/10.18632/oncotarget.17420
Publication status	Published - 25 Apr 2017

Keywords

Sphingosine kinase 2
multiple myeloma
MM
chemotherapeutic agents
bortezomib

Access to Document

10.18632/oncotarget.17420Licence: CC BY 3.0

Pyne-Pyne-Oncotarget-2017-Sphingosine-kinase-2-and-multiple-myelomaFinal published version, 659 KBLicence: CC BY 3.0

Cite this

@article{036d41dd3d1b47c68917c7704a7acf56,

title = "Sphingosine kinase 2 and multiple myeloma",

abstract = "News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.",

keywords = "Sphingosine kinase 2, multiple myeloma, MM, chemotherapeutic agents, bortezomib",

author = "Pyne, \{Nigel J.\} and Susan Pyne",

year = "2017",

month = apr,

day = "25",

doi = "10.18632/oncotarget.17420",

language = "English",

volume = "8",

pages = "43596--43597",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "24",

}

TY - JOUR

T1 - Sphingosine kinase 2 and multiple myeloma

AU - Pyne, Nigel J.

AU - Pyne, Susan

PY - 2017/4/25

Y1 - 2017/4/25

N2 - News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.

AB - News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.

KW - Sphingosine kinase 2

KW - multiple myeloma

KW - MM

KW - chemotherapeutic agents

KW - bortezomib

U2 - 10.18632/oncotarget.17420

DO - 10.18632/oncotarget.17420

M3 - Article

SN - 1949-2553

VL - 8

SP - 43596

EP - 43597

JO - Oncotarget

JF - Oncotarget

IS - 24

M1 - 17420

ER -

Sphingosine kinase 2 and multiple myeloma

Abstract

Keywords

Access to Document

Fingerprint

Cite this